Dr Horton Inc (DHI) — 13F Filings Explorer (Q2 2026)

DHI ranks #334 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

DHI is a top-conviction position for Greenhaven Associates Inc — at 6.6% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in DHI belongs to Capital World Investors, but the position matters far more to Greenhaven Associates Inc, who has 6.6% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Fidelity has added to its DHI position for two straight quarters, increasing it by $468.0M to reach $1.5B today.

JPMorgan has trimmed its DHI position for two straight quarters, cutting it by $741.8M while still holding $251.0M.

DHI is up 0.6% today, and institutions have been net buyers of $8.5B this quarter — today's price move and the underlying institutional flow are pointing the same direction.

DHI posted net income of $3.1B over the trailing twelve months, and currently trades at a P/E of 14.4.

• Profitable — net income of $3.1B over the trailing twelve months
• Revenue declined 3.5% year over year
• Net income declined year over year, from $4.0B to $3.1B
• Generated $3.4B in positive operating cash flow
• Liabilities run 0.44x equity — within a conventional range